Drug Database
Back to search

Poland· PL-100452811

Ramlolan

A ramipril und amlodipin product containing ramiprilum + amlodipinum, registered in Poland by G.L. Pharma GmbH. The same ATC class is registered in 5 of our 19 countries.

ATC C09BB07

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedRamlolanATCC09BB07REGISTER NO.PL-100452811PACKS LISTED10CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ramiprilum + amlodipinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ramipril und amlodipin is registered in 5 of 19 countries.

Countries holding a registration under ATC C09BB07 (ramipril und amlodipin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 5 of them publish a price we can compare per daily dose
Search ramipril und amlodipin products by name

Ramipril und amlodipin · ATC C09BB07

5 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Italyprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Ramiprilum + Amlodipinum
Manufacturer
G.L. Pharma GmbH
Country
Poland (PL)
ATC code
C09BB07
ATC class
Ramipril und Amlodipin
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 10

  • gtin
    05909991503888
  • gtin
    05909991503895
  • gtin
    05909991503901
  • gtin
    05909991503918
  • gtin
    05909991503925
  • gtin
    05909991503932
  • gtin
    05909991503949
  • gtin
    05909991503956
  • gtin
    05909991503963
  • gtin
    05909991503970

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

17 interactions on record for ramipril und amlodipin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ramipril und amlodipin against other medicinesHow interaction checks work

Ramipril und amlodipin · interactions on record

17 records

17 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Ramipril und amlodipin in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ramipril und amlodipin products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Ramipril/Amlodipin 1a Pharma, Ramipril/Amlodipin Genericon
  • Bulgaria · Вивейс Дуо, Егирамлон
  • Cyprus · Diaspil, Rami-Amlo
  • Czechia · Egiramlon, Piramil Combi
  • Germany · Ramidipin, Ramipril Plus Amlodipin Aristo
  • Estonia · Ramdacordia, Ramipril/Amlodipine Sandoz
  • Spain · Amlodipino/Ramipril Aristo, Tarlodix
  • Finland · Rameam
  • France · Preminor
  • United Kingdom (Northern Ireland) · Ramipril/Amlodipine Dawa
  • Greece · Diaspil, Rami-Amlo
  • Croatia · Amora, Pinmirol
  • Hungary · Egiramlon
  • Italy · Alamut, Duotens
  • Lithuania · Ramlon
  • Latvia · Ramdacordia, Ramipril/Amlodipine Sandoz
  • Portugal · Mepranil, Ramipril + Amlodipina Krka
  • Sweden · Ramipril/Amlodipine Adamed
  • Slovenia · Rameam, Ramelso
  • Slovakia · Amirap, Egiramlon

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e3424a45-68f2-4e27-9552-d2267bd2124c
GET /v1/drugs/e3424a45-68f2-4e27-9552-d2267bd2124c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "5 mg + 10 mg",
  "packaging": "05909991503888 ¦ Rp ¦ 148118\n28 kaps.\n05909991503895 ¦ Rp ¦ 148119\n100 kaps.\n05909991503901 ¦ Rp ¦ 148120\n32 kaps.\n05909991503918 ¦ Rp ¦ 148121\n90 kaps.\n05909991503925 ¦ Rp ¦ 148122\n56 kaps.\n05909991503932 ¦ Rp ¦ 148123\n60 kaps.\n05909991503949 ¦ Rp ¦ 148124\n30 kaps.\n05909991503956 ¦ Rp ¦ 148125\n96 kaps.\n05909991503963 ¦ Rp ¦ 148126\n98 kaps.\n05909991503970 ¦ Rp ¦ 148127\n91 kaps.",
  "substance": "Ramiprilum 5 mg + Amlodipini besilas 13.868 mg",
  "common_name": "Ramiprilum + Amlodipinum",
  "pl_product_id": "100452811",
  "pozwolenie_nr": "27563",
  "auth_procedure": "DCP",
  "authorisation_validity": "2027-12-16"
}
API referenceMCP serverPlans

See everything about ramipril und amlodipin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console